BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10022222)

  • 1. Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
    Salgia R; Hedges TR; Rizk M; Reimer RH; Skarin AT
    Lung Cancer; 1998 Nov; 22(2):149-52. PubMed ID: 10022222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
    Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
    Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic retinopathy and anti-recoverin antibodies].
    Bataller L; Graus F; Dalmau J
    Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
    [No Abstract]   [Full Text] [Related]  

  • 4. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.
    Savchenko MS; Bazhin AV; Shifrina ON; Demoura SA; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2003 Sep; 41(3):363-7. PubMed ID: 12928127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL; Thirkill CE
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated retinopathy during treatment for small-cell lung carcinoma.
    Kashiwabara K; Nakamura H; Kishi K; Yagyu H; Sarashina G; Kobayashi K; Matsuoka T
    Intern Med; 1999 Jul; 38(7):597-601. PubMed ID: 10435368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
    Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
    Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
    Thirkill CE; Keltner JL; Tyler NK; Roth AM
    Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
    Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
    Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated retinopathy.
    Thirkill CE; Roth AM; Keltner JL
    Arch Ophthalmol; 1987 Mar; 105(3):372-5. PubMed ID: 2950846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.
    Polans AS; Witkowska D; Haley TL; Amundson D; Baizer L; Adamus G
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9176-80. PubMed ID: 7568096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy.
    Adamus G; Amundson D; MacKay C; Gouras P
    Arch Ophthalmol; 1998 Feb; 116(2):251-3. PubMed ID: 9488286
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer-associated retinopathy in a patient with endometrial cancer.
    Ohkawa T; Kawashima H; Makino S; Shimizu Y; Shimizu H; Sekiguchi I; Tsuchida S
    Am J Ophthalmol; 1996 Nov; 122(5):740-2. PubMed ID: 8909222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated retinopathy with presumed vasculitis.
    Suzuki T; Obara Y; Sato Y; Saito G; Ichiwata T; Uchiyama T
    Am J Ophthalmol; 1996 Jul; 122(1):125-7. PubMed ID: 8659589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
    Maeda A; Ohguro H; Nabeta Y; Hirohashi Y; Sahara H; Maeda T; Wada Y; Sato T; Yun C; Nishimura Y; Torigoe T; Kuroki Y; Sato N
    Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental, cancer-induced retinopathy.
    Thirkill CE
    Ocul Immunol Inflamm; 1997 Mar; 5(1):55-65. PubMed ID: 9145694
    [No Abstract]   [Full Text] [Related]  

  • 19. Paraneoplastic retinopathy syndrome.
    Thirkill CE; Roth AM; Keltner JL
    Ophthalmology; 1993 Feb; 100(2):147. PubMed ID: 8437815
    [No Abstract]   [Full Text] [Related]  

  • 20. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H; Ogawa K; Nakagawa T
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.